本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Allogene Therapeutics Inc.

2.17
+0.14006.90%
盤後2.170.00000.00%16:10 EDT
成交量:615.51萬
成交額:1,333.80萬
市值:7.49億
市盈率:-3.33
高:2.21
開:2.05
低:2.05
收:2.03
52周最高:4.46
52周最低:1.04
股本:3.45億
流通股本:2.67億
量比:1.24
換手率:2.31%
股息:- -
股息率:- -
每股收益(TTM):-0.6510
每股收益(LYR):-0.8652
淨資產收益率:-42.39%
總資產收益率:-22.08%
市淨率:1.72
市盈率(LYR):-2.51

資料載入中...

2026/03/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/12

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/12

重要事件披露

Form 8-K - Current report
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/10/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/11

重要事件披露

Form 8-K - Current report
2025/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/13

重要事件披露

Form 8-K - Current report